Reena Shakya
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
117
Citations
3,720
Est. group size
—
Recurring co-author estimate
Active years
26
Publishing since 2001
Reena Shakya's research focuses on the molecular biology of cancer, particularly using laboratory models of pancreatic cancer and glioma (a type of brain tumor) to study how tumors develop and respond to treatment. Work includes studying DNA repair proteins in mammary (breast) tumor formation and testing drug therapies, such as hypomethylating agents (drugs that alter DNA modification patterns to affect gene activity), in cancer models. The research combines genetic, genomic, and experimental approaches to understand tumor progression and identify potential treatment strategies.
Publication output was relatively steady at a modest pace through most of the last decade, with a sharp, unusual spike in 2023 followed by little to no output in 2024.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Data from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Data from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Data from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Supplementary Figure Legend from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Supplementary Figures 1 - 5 from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Supplementary Tables 1 - 2 from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Supplementary Tables 1 through 7 from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Figures 1 through 6 from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Figure Legend from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Figure Legend from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Figures 1 through 6 from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Tables 1 through 7 from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Data from The Transcriptional Regulatory Network of Proneural Glioma Determines the Genetic Alterations Selected during Tumor Progression
2023
- Supplementary Figures 1 - 5 from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Supplementary Figure Legend from Hypomethylating Therapy in an Aggressive Stroma-Rich Model of Pancreatic Carcinoma
2023
- Cancer Research×7
- Oncotarget×3
- Research Square×3
- Journal for ImmunoTherapy of Cancer×2
- Journal of Visualized Experiments×2
- Emily Cybulla
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ruben C. Petreaca
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ju Hwan Cho
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Walter J. Zahurancik
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Dipika Gupta
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile